OsoBio Appoints Catherine Buck Director of Manufacturing
Buck has 20-plus years of experience managing pharma and commercial manufacturing plants. - April 02, 2014
OsoBio Reaffirms DCAT Partnership Through New Leadership Positions
OsoBio President Milton Boyer to serve as vice president of DCAT's executive committee. - December 19, 2013
OsoBio Appoints Lindsey Pruitt to Manage East Coast Business Development Efforts
Working in her new capacity in OsoBio’s Philadelphia location, Pruitt will identify and foster new business opportunities throughout the Northeast. - July 22, 2013
OsoBio Names Kathleen Larese Director of Laboratories
OsoBio has named Kathleen Larese director of laboratories. As part of OsoBio’s quality control department, the microbiology and chemistry laboratories that Larese now directs are responsible for environmental monitoring, analytical method development, and testing all incoming raw materials,... - June 26, 2013
OsoBio Appoints David M. Lee Vice President of Quality
OsoBio has named David M. Lee vice president of quality. Lee is responsible for overseeing all quality-related functions to ensure the company’s continued compliance with Current Good Manufacturing Practices (cGMP), including quality systems, quality control and manufacturing quality... - May 10, 2013
OsoBio President to Join Injectable Trends Discussion at DCAT Week
OsoBio President Milton Boyer and other experts will examine industry's shortages. - February 22, 2013
OsoBio Appoints Alan P. Heim as Vice President of Human Resources
OSO BioPharmaceuticals Manufacturing, LLC, has appointed Alan P. Heim as vice president of human resources. In his capacity, Heim administers all policies and programs that affect personnel at OsoBio, including issues such as organizational planning; recruitment, hiring and training; employee... - October 05, 2012
OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite
State-of-the-art line will increase capacity and yield of liquid, suspension and lyophilized products. - May 02, 2012
OsoBio Appoints Marian Meyer Director of Labs
Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012
Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing
Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012
VP at OSO BioPharmaceuticals Elected to DCAT Board of Directors
Milton Boyer to serve three-year term at leading industry association. - November 03, 2011
Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says
A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011
OSO BioPharmaceuticals Receives DEA Approval to Handle Controlled Substances
OSO BioPharmaceuticals Manufacturing, LLC, has been granted research and analytical licenses by the U.S. Drug Enforcement Administration (DEA) to handle Schedule II through V controlled substances. - June 24, 2011
OSO BioPharmaceuticals Manufacturing LLC Honored for Corporate Efforts to Protect Integrity of Rio Grande
OSO BioPharmaceuticals Manufacturing, LLC, has received the Pollution Prevention Award for its efforts to protect water quality in the Rio Grande River. The honor was awarded by the Albuquerque Bernalillo County Water Utility as part of its Pollution Prevention Program (P2 Program). The P2... - May 13, 2011
OSO BioPharmaceuticals to Sponsor Forum on Subcutaneous Biologic Drug Delivery Trends and Best Practices at DCAT Week
The 2011 DCAT Week Biologics Forum will present regulatory and pharmaceutical industry leaders discussing current requirements, trends and best practices for subcutaneous biologic drug delivery systems. - February 24, 2011
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors
Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA). Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being... - January 28, 2011
OSO BioPharmaceuticals Taps Craig Mastenbaum to Lead West Coast Business Development
OSO BioPharmaceuticals Manufacturing, LLC, has named Craig Mastenbaum director of new business development for its West Coast market. Mastenbaum brings to OsoBio more than 30 years of leadership experience in clinical and contract liquid, lyophilized, ampule and syringe product manufacturing. Most... - January 21, 2011
OSO BioPharmaceuticals Appoints Susan Schniepp VP of Quality
OSO BioPharmaceuticals Manufacturing, LLC, has named Susan Schniepp as vice president of quality. In managing all operational quality-related issues, Schniepp is responsible for cGMP compliance of OsoBio’s facility. Quality-related matters concerning validation as well as regulatory affairs,... - September 30, 2010